Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 2009
Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia
Shi Liang, Kevin Pong, Cathleen Gonzales, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 7, 2008
Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels
David R Riddell, Hua Zhou, Kevin Atchison, et al.
Geroscience
|
March 27, 2024
Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders
Yazhou Li, Kelli L Vaughan, Yun Wang, et al.
Neurobiology of Disease
|
July 14, 2006
Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis
Erika L F Holzbaur, David S Howland, Nicholas Weber, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 29, 2007
Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities
Benfang Ruan, Kevin Pong, Flora Jow, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 19, 2008
Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade
J Steven Jacobsen, Thomas A Comery, Robert L Martone, et al.
Neuron
|
December 6, 2016
Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington's Disease Models
Vahri Beaumont, Sheng Zhong, Hai Lin, et al.
Journal of Medicinal Chemistry
|
January 8, 2014
Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator
Lei Zhang, Gayatri Balan, Gabriela Barreiro, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 13, 2009
Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease
Robert L Martone, Hua Zhou, Kevin Atchison, et al.
Journal of Medicinal Chemistry
|
August 18, 2017
Discovery and Characterization of (R)-6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman Primates
Antonia F Stepan, Michelle M Claffey, Matthew R Reese, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 2009
Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia
Shi Liang, Kevin Pong, Cathleen Gonzales, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 7, 2008
Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels
David R Riddell, Hua Zhou, Kevin Atchison, et al.
Geroscience
|
March 27, 2024
Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders
Yazhou Li, Kelli L Vaughan, Yun Wang, et al.
Neurobiology of Disease
|
July 14, 2006
Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis
Erika L F Holzbaur, David S Howland, Nicholas Weber, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 29, 2007
Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities
Benfang Ruan, Kevin Pong, Flora Jow, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 19, 2008
Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade
J Steven Jacobsen, Thomas A Comery, Robert L Martone, et al.
Neuron
|
December 6, 2016
Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington's Disease Models
Vahri Beaumont, Sheng Zhong, Hai Lin, et al.
Journal of Medicinal Chemistry
|
January 8, 2014
Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator
Lei Zhang, Gayatri Balan, Gabriela Barreiro, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 13, 2009
Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease
Robert L Martone, Hua Zhou, Kevin Atchison, et al.
Journal of Medicinal Chemistry
|
August 18, 2017
Discovery and Characterization of (R)-6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman Primates
Antonia F Stepan, Michelle M Claffey, Matthew R Reese, et al.
Page
of 10